Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program.

Treatment retention rates provide a proxy measure for long-term efficacy, safety, tolerability, and adherence. The consistently high retention rates we found suggest that cenobamate may be an effective and well-tolerated new treatment option for people with drug-resistant focal seizures.